MYC and cancer: Given the renewed interest in Aurora A as a drug target based on the recently discovered role of Aurora A in controlling c-Myc protein levels in cancers such as neuroblastoma (113, 114), new inhibitor discovery efforts leveraging the approaches described here could aid not only in developing better tools for cell biology experiments but also in fully realizing the therapeutic potential of inhibiting Aurora A.